Revenue
2018
2019
2020
2021
2022
2023
2024
2025
PUMA BIOTECHNOLOGY, INC. (PBYI)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $228.4M | $230.5M | $235.6M | $228.0M | $253.2M | $225.1M | $272.3M | $251.0M | $27.7M | — | — | — | — | — | — |
| Research & development | $62.1M | $54.9M | $50.4M | $52.2M | $71.9M | $97.7M | $132.9M | $164.9M | $207.8M | $222.8M | $208.5M | $122.9M | $45.0M | $49.6M | $826,000 |
| Operating expenses | — | — | — | — | — | $255.5M | $311.3M | $345.6M | $320.1M | $276.6M | $240.3M | $142.3M | $54.8M | $74.5M | $10.2M |
| Operating income | $37.3M | $31.0M | $32.6M | $23.7M | $1.3M | −$30.4M | −$39.0M | −$94.7M | −$292.4M | −$276.6M | −$240.3M | −$142.3M | −$54.8M | −$74.5M | −$10.2M |
| EBITDAderived | $48.2M | $42.5M | $44.2M | $33.6M | $12.6M | −$20.4M | −$31.0M | −$87.3M | −$289.6M | −$275.4M | −$239.5M | −$141.6M | −$54.4M | −$74.2M | −$10.1M |
| Net income | $31.1M | $30.3M | $21.6M | $2,000 | −$29.1M | −$60.0M | −$75.6M | −$113.6M | −$292.0M | −$276.0M | −$239.3M | −$142.0M | −$54.7M | −$74.4M | −$10.2M |
| Basic EPSper diluted share | $0.62 | $0.62 | $0.46 | $0.00 | -$0.72 | -$1.52 | -$75,595.00 | -$2.99 | -$7.85 | -$8.29 | -$7.45 | -$4.73 | -$1.90 | -$3.42 | -$1.32 |
| Diluted EPSper diluted share | $0.61 | $0.62 | $0.45 | $0.00 | -$0.72 | -$1.52 | -$1.95 | -$2.99 | -$7.85 | -$8.29 | -$7.45 | -$4.73 | -$1.90 | -$3.42 | -$1.32 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 12, 2026Form 4 · 10b5-1 | WILSON TROY EDWARDDirector | SellCommon Stock | 10.8K | $7.20 | $77.8K | 59.8K |
| Jun 12, 2026Form 4 · 10b5-1 | Stuglik Brian MDirector | SellCommon Stock | 8.1K | $7.20 | $58.3K | 113.9K |
| Jun 12, 2026Form 4 · 10b5-1 | Senderowicz AdrianDirector | SellCommon Stock | 27.0K | $7.20 | $194.4K | 27.0K |
| Jun 12, 2026Form 4 · 10b5-1 | MOYES JAY MDirector | SellCommon Stock | 22.0K | $7.22 | $158.8K | 58.3K |
| Jun 12, 2026Form 4 · 10b5-1 | Dorval AllisonDirector | SellCommon Stock | 11.6K | $7.20 | $83.6K | 90.8K |